Oncology/Hematology
Hemophilia
More in Hemophilia
Factor VIII replacement therapy provides protection from bleeds with once-weekly dosing
Feb 23, 2023
Model predicts valoctocogene roxaparvovec could maintain mild hemophilia levels for 5 years
Feb 23, 2023
Hemgenix reduced rate of annual bleeds, eliminated need for factor IX prophylaxis therapy
Nov 22, 2022
Gene therapy continues to show promise in clinical trials, but is it ready for the clinic?
Nov 17, 2022
"This is the most exciting time ever" to be a hematologist, says ASH President Jane Winter, MD
Sep 26, 2022
Eric Winer, MD, talks about how growing up with hemophilia helped him connect with patients
Aug 02, 2022
Valoctocogene roxaparvovec significantly increased factor VIII activity, reduced bleeding
Mar 16, 2022
Monthly infusion vs on-demand bypassing agents effective in patients with or without inhibitors
Dec 14, 2021
Reading Room
Continuing Medical Education
1.00 CME Credits